New Benevity Impact Labs Research Reveals a Confidence Gap Among Global Grantmakers Aleafia Health to Participate in the Cantor Fitzgerald Cannabis Forum Webcast on June 16 at 10:00 a.m. ET
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
Aleafia Health to Participate in the Cantor Fitzgerald Cannabis Forum Webcast on June 16 at 10:00 a.m. ET
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
GENFIT: June 15, 2021 Combined Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening
Quorum of 18.19% on first convening Combined Shareholders Meeting will be reconvened on June 30,…
GENFIT: June 15, 2021 Combined Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening
Quorum of 18.19% on first convening Combined Shareholders Meeting will be reconvened on June 30,…
Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced…
Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced…
Medexus Announces Graduation to the Toronto Stock Exchange
TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus”…
Medexus Announces Graduation to the Toronto Stock Exchange
TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus”…
SpringWorks Therapeutics Announces Presentation of Updated Interim Data from the Phase 2b ReNeu Trial at the 2021 Children’s Tumor Foundation NF Conference
Additional Follow-up of First 20 Adult Patients Enrolled Continues to Show Encouraging Efficacy and Tolerability…
SpringWorks Therapeutics Announces Presentation of Updated Interim Data from the Phase 2b ReNeu Trial at the 2021 Children’s Tumor Foundation NF Conference
Additional Follow-up of First 20 Adult Patients Enrolled Continues to Show Encouraging Efficacy and Tolerability…
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
Expands Eton’s Adrenal Insufficiency Orphan Drug Portfolio ZENEO® Hydrocortisone is Expected to be the First…
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
Expands Eton’s Adrenal Insufficiency Orphan Drug Portfolio ZENEO® Hydrocortisone is Expected to be the First…
Editas Medicine Reports Inducement Grants to New Chief Scientific Officer and Chief Regulatory Officer
CAMBRIDGE, Mass., June 15, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading…
Editas Medicine Reports Inducement Grants to New Chief Scientific Officer and Chief Regulatory Officer
CAMBRIDGE, Mass., June 15, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading…
Spero Therapeutics Announces the Initiation of Bronchoalveolar Lavage and Renal Impairment Clinical Trials of SPR206
CAMBRIDGE, Mass., June 15, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Spero Therapeutics Announces the Initiation of Bronchoalveolar Lavage and Renal Impairment Clinical Trials of SPR206
CAMBRIDGE, Mass., June 15, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Senti Bio Signs Lease Agreement and Begins Design of Clinical and Commercial-Scale Manufacturing Facility for Allogeneic CAR-NK Cell Therapies
– 92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of…
Senti Bio Signs Lease Agreement and Begins Design of Clinical and Commercial-Scale Manufacturing Facility for Allogeneic CAR-NK Cell Therapies
– 92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of…
Inventiva to participate at the SVB Leerink CybeRx Series: Liver Disease Day
Daix (France), June 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
Inventiva to participate at the SVB Leerink CybeRx Series: Liver Disease Day
Daix (France), June 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…